Genvor Incorporated (GNVR)
OTCMKTS
· Delayed Price · Currency is USD
0.615
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST
Genvor Company Description
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security.
The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms.
Genvor Incorporated is based in Henderson, Nevada.
Genvor Incorporated
| Country | United States |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 5 |
| CEO | Chad Pawlak |
Contact Details
Address: 1550 W Horizon Ridge Pkwy Henderson, Nevada 89012 United States | |
| Phone | 715 903 6473 |
| Website | genvor.com |
Stock Details
| Ticker Symbol | GNVR |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Chad Pawlak Sr. | Chief Executive Officer, Chief Financial Officer and Director |
| Dr. Jesse M. Jaynes Ph.D. | Chief Research Officer, Chief Scientific Officer and Director |
| Dr. Windy Dean-Colomb M.D., Ph.D. | Chief Clinical Officer |
| Dr. George Stavrides | Executive Vice President of Business Development and Commercialization |